Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cells
RNA-seq (gene expression) · human · 27 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 27 samples: 9 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Comparative network-based analysis of toll-like receptor agonist, L-pampo signaling pathways in immune and cancer cellsScientific reports · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE264131_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1101035 and SRA study SRP502084. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 27 samples.
How we read this: 9 replicated groups read from 27 sample titles; they account for 27 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8212612 differentiated THP-1 (monocyte) cells, Non-treatment, 0 hour, replicate 1 differentiated THP-1 (m…
- GSM8212613 differentiated THP-1 (monocyte) cells, Non-treatment, 0 hour, replicate 2 differentiated THP-1 (m…
- GSM8212614 differentiated THP-1 (monocyte) cells, Non-treatment, 0 hour, replicate 3 differentiated THP-1 (m…
- GSM8212615 differentiated THP-1 (monocyte) cells, L-pampo™ 1x, 3 hours, replicate 1 differentiated THP-1 (m…
- GSM8212616 differentiated THP-1 (monocyte) cells, L-pampo™ 1x, 3 hours, replicate 2 differentiated THP-1 (m…
- GSM8212617 differentiated THP-1 (monocyte) cells, L-pampo™ 1x, 3 hours, replicate 3 differentiated THP-1 (m…
- GSM8212618 differentiated THP-1 (monocyte) cells, L-pampo™ 1x, 6 hours, replicate 1 differentiated THP-1 (m…
- GSM8212619 differentiated THP-1 (monocyte) cells, L-pampo™ 1x, 6 hours, replicate 2 differentiated THP-1 (m…
- GSM8212620 differentiated THP-1 (monocyte) cells, L-pampo™ 1x, 6 hours, replicate 3 differentiated THP-1 (m…
- GSM8212621 PC-3 (prostate cancer) cells, Non-treatment, 0 hour, replicate 1 PC-3 (prostate cancer) …
- GSM8212622 PC-3 (prostate cancer) cells, Non-treatment, 0 hour, replicate 2 PC-3 (prostate cancer) …
- GSM8212623 PC-3 (prostate cancer) cells, Non-treatment, 0 hour, replicate 3 PC-3 (prostate cancer) …
- GSM8212624 PC-3 (prostate cancer) cells, L-pampo™ 1x, 3 hours, replicate 1 PC-3 (prostate cancer) …
- GSM8212625 PC-3 (prostate cancer) cells, L-pampo™ 1x, 3 hours, replicate 2 PC-3 (prostate cancer) …
- GSM8212626 PC-3 (prostate cancer) cells, L-pampo™ 1x, 3 hours, replicate 3 PC-3 (prostate cancer) …
- GSM8212627 PC-3 (prostate cancer) cells, L-pampo™ 1x, 6 hours, replicate 1 PC-3 (prostate cancer) …
- GSM8212628 PC-3 (prostate cancer) cells, L-pampo™ 1x, 6 hours, replicate 2 PC-3 (prostate cancer) …
- GSM8212629 PC-3 (prostate cancer) cells, L-pampo™ 1x, 6 hours, replicate 3 PC-3 (prostate cancer) …
- GSM8212630 SW620 (colon cancer) cells, Non-treatment, 0 hour, replicate 1 SW620 (colon cancer) ce…
- GSM8212631 SW620 (colon cancer) cells, Non-treatment, 0 hour, replicate 2 SW620 (colon cancer) ce…
- GSM8212632 SW620 (colon cancer) cells, Non-treatment, 0 hour, replicate 3 SW620 (colon cancer) ce…
- GSM8212633 SW620 (colon cancer) cells, L-pampo™ 1x, 3 hours, replicate 1 SW620 (colon cancer) ce…
- GSM8212634 SW620 (colon cancer) cells, L-pampo™ 1x, 3 hours, replicate 2 SW620 (colon cancer) ce…
- GSM8212635 SW620 (colon cancer) cells, L-pampo™ 1x, 3 hours, replicate 3 SW620 (colon cancer) ce…
- GSM8212636 SW620 (colon cancer) cells, L-pampo™ 1x, 6 hours, replicate 1 SW620 (colon cancer) ce…
- GSM8212637 SW620 (colon cancer) cells, L-pampo™ 1x, 6 hours, replicate 2 SW620 (colon cancer) ce…
- GSM8212638 SW620 (colon cancer) cells, L-pampo™ 1x, 6 hours, replicate 3 SW620 (colon cancer) ce…
- GSE328715 Cell autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis 25 samples shares receptor
- GSE270928 Single-cell sequencing of full-length transcripts and T-cell receptors with automated high-throughput Smart-seq3 [HT SS3] 6415 samples shares receptor
- GSE313992 Comparative Immunotoxicity and Transcriptomic Profiling of Seven PFAS in THP-1 Macrophages 252 samples shares comparative
- GSE222196 Treatment of prostate cancer cell lines with Androgen Receptor and Receptor Tyrosine Kinase inhibitors 246 samples shares receptor
- GSE280267 Glycine Receptor Activity in β Cells Is Downregulated in Type 2 Diabetes and After High Glucose Culture 199 samples shares receptor
- GSE212836 Comparative Molecular Analysis of IL-17A and IL-23 Pathway Inhibition in Moderate-to-Severe Psoriasis: 4-Week Results from IXORA-R 199 samples shares comparative
- GSE284956 Overcoming intrinsic mechanisms of cell cycle inhibitor resistance in estrogen receptor-positive (ER+) breast cancer 180 samples shares receptor
- GSE326530 Comparative circadian transcriptome analysis reveals dampened and phase-advanced rhythms in sun-exposed skin 160 samples shares comparative
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.